Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. The Lancet Diabetes & Endocrinology, vol
This bundle contains 30 sticks of our powerful glutathione white supplement for glowing skin
F., Sehar, Z., Fatma, M., Masood, A
We encourage you to schedule a consultation so we can assess your specific needs
The trade-off is that if you wake up extremely hungry or eat a big breakfast before the medication fully engages, you may not feel the full appetite-suppressing effect during your early meals
All authors were involved in the preparation and review of the manuscript and approved the final submitted version